MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Samir Hanash, M.D., Ph.D.
Co-Leader: Project 4
Fred Hutchinson Cancer Research Center
Molecular Diagnostic
PO BOX 19024
1100 Fairview Ave N, M5-C800
Seattle, WA 98109
Phone: 206-667-5703
Fax: 206-667-2537
Email: shanash@fhcrc.org


Co-Project Leader: Project 4, Professor of Human Biology, (Fred Hutchinson Cancer Research Center)
Dr. Hanash is Director of Molecular Diagnostics and the Fred Hutchinson Cancer Center. His research interests have focused on the global profiling of cancer even before the merits of such an effort were widely recognized. He has also recognized the merits of integrated genomic and proteomic profiling and has been among the very first to integrate the molecular analysis of cancer at the genomic, transcriptomic and proteomic levels, with substantial reliance on array technology. Another important area that he has pioneered is the application of proteomics to the identification of tumor antigens that induce an antibody response in cancer patients. The use of natural tumor protein microarrays has allowed assessment of the antigenic properties of proteins in their natural state as derived from tumors, leading to the isolation of those tumor antigens with the greatest potential to provide a molecular signature for the detection of cancer at an early stage. Dr Hanash has just finished a three-year term as the inaugural president of the Human Proteome Organization.

[ Back ]
crumpnews events